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BACTERIAL CONTROL OF MOSQUITO LARVAE: INVESTIGATION oFSTABILITY OF BACILLUS THURINGIENSIS VAR. ISRAELENSIS
AND BACILLUS SPHAERICUS STANDARD POWDERS
ISABELLE THIERY AND SYLVIANE HAMON
Uniti des Bactiries Entomopathogbnes, Institut Pasteur,25 rue du Docteur Roux,75724 paris cedex 15, France
ABSTRACT' Bacillus thuringiensis var. israelensis and Bacillus sphaericus products were assayed againsttheir respective reference powders IPS82 and SPH88. Since their production in 1982 and l9gg, the iotency andlarvicidal activity of these standard powders have been regularly ciecked on their test insects Aedes-aegypti (tor
IPS82) or Culex pipiens (for SPH88). Over the l6-year eviluation period of IpS82 and lo-year evaluation period
of SPH88, their potencies were considered stable. The global mean of each year's mean showed a coefficient
of variation of less than 20vo. Lawal rearing was the mosl important factor in tihe reproducibility of the bioassay,
although some variation-also originated from the person performing the bioassay. ihis study ;emonstrated that
the SPH88 standard could be kept in a stock susplnsion ut 4"c foi3 years without loss of 
'potency. 
Mor.ou".,
after 9 years of storage in suspension, only a 2-fold decrease in the potency of SpH88 was detected.
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The bacterium Bacillus thuringiensis var israe-
lensis (B.t.i.) de Barjac has been used since 1980
for the control of mosquito and blackfly larval pop-
ulations. In a similar context, Bacillus sphaericus
Neide has been used since 1987 to combat Culex
Linnaeus and Anopheles Linnaeus mosquito larvae.
Different preparations, such as liquids, powders,
granules, pellets, micropellets, microgranules, and
fizzy tablets, are applied to breeding sites depend-
ing on the mosquito species and their biotope (Thi-
6ry et al. 1996). Before application, the potency of
these bacterial preparations is evaluated and com-
pared by titrating them against reference standard
powders. These standard powders are dispatched by
the Unit of Bact6ries Entomopathogbnes, Institut
Pasteur, Paris, France, upon request. Standardiza-
tion performance depends upon the reproducibility
of bioassays and the stability of the larvicidal ac-
tivity of these reference powders. In this note we
describe the stability of the standard powders com-
monly used for B.t.i. and B. sphaericus products.
To perform standardized bioassays, protocols for
mosquito rearing as well as bioassay methods and
Aedes aegypti L. (Bora-Bora strain) eggs are avail-
able upon request from the Unit of Bactdries En-
tomopathogbnes, Institut Pasteur.
Bacillus thuringiensis var. israelensis (strain
1884) lyophilized powder (IPS82) is the interna-
tional standard powder for B.t.i. preparations (de
Barjac and Larget-Thi6ry 1984). According to its
relation with IPS78 (the first B.r.i. standard, which
had a potency of 1,0OO ITU/mg [de Ba{ac and Lar-
Eet 19791), tPS82 has a potency of 15,000 ITU/mg.
The potency of a B.t.i. product is thus defined in
ITU/mg on Ae. aegypti (Bora-Bora strain) young
4th-instar larvae according to the following for-
mula:
LC5o (IPS82) x 15,0O0/LCso (B.t.i. product),
in which LCro represents the lethal concentration
inducing 5O7o lawal mortality after exposure of the
larval population for 24 h.
Bacillus sphaericus products are comparatively
bioassayed against B. sphaericus strun 2362 lyoph-
ilized standard powder, which is called SPH88. The
potency is calculated according to the formula men-
tioned above, although the LCro is recorded after 48
h of exposure of the larval population. The potency
of this standard has been determined against the
first B. sphaericus standard powder called RB80,
which had a potency of 1,0O0 ITU/mg (Bourgouin
et al. 1984) as 1,70O ITU/mg using Culex pipiens
Linnaeus (Montpellier strain) young 4th-instar lar-
vae (Thi6ry, unpublished data). Likewise, another
B. sphaericus (strain 2297) lyophrlized standard
powder, SPH84, was determined to contain 1.,500
toxic units/mg on Cx. pipiens (Mon@ellier strain)
in bioassays against RB8O (Thi6ry, unpublished
data). These 2 standard powders were produced to
overcome problems with stability of the larvicidal
activity and reproducibility when using the RB80
standard (Fig. 1). Since the preparation of SPH88
and SPH84, the RB80 standard has not been avail-
able. The SPH84 standard is usually not dispatched
because most of the B. sphaericus products are
made with sttain 2362. Nevertheless, the potency
of SPH84 is verified and it can also be used as an
internal standard. As for IPS82 (de Barjac and Lar-
get-Thi6ry 1984), the heat-stabilities of SPH84 and
SPH88 powders at 50oC for 4 wk have been
checked and the mean of their LCros was identical
to that of control powder kept at 5"C (Thi6ry, un-
published data). Since 1988, SPH88 powder has
been used as the acknowledged standard to rate the
potency of B. sphaericzs products based on strain
2362.
Ratings in ITU allow comparison of larvicidal
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Fig. l. Mean of the larvicidal activity of 3 Bacillus sphaericus standard powders (RB80, SpH84, and SpHgg) from
1,982 to 1997 against Culex pipiens 4th-instar larvae. The LCro (mg/liter) ."p."*"nt, the lethal concentration that kills
l0! of the larval population exposed for 48 h. The bars represent the mean-of LCros of at least 12 bioassays with the
indication of the standard deviation (SD).
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Fig' 2' Mean of the larvicidal activity of the Bacillus thuringiensis var. israelensis standard powder IpSg2 from1982 to 1997 against Aedes aegypti (Bora-Bora strain) 4th-instar larvae. The LCro (mg/liter) ripresents the lethalconcentration that kills 5ov1 of the larval population exposed for 24 h or 48 h. The dots represent the mean of LCros
of at least 12 bioassays with the indication of the standard deviation (SD).
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activity of bacterial formulations between produc_
9rs and laboratories, thus avoiding variationi due to
inninsic parameters of the method. Indeed, 2 main
protocols are used for mosquito bioassays using
different cups, volumes, watei depth, dilutions, and
ly1ber! of larvae (de Barjac and Larget_Thi6ry
1984, 
-Mclaughlin et al. 1984). Moreove! the spe_
cies of Culex used are not the same. In some coun_
ties Culex quinquefasciafzs Say are used instead
of Cx. pipiens. Efficacy of standardization is valu-
able if standard bioassays are as reproducible as
possible with little variation of the LCro. To achieve
this it is necessary to regularly check the larvicidal
activity of the standard powders.
Since their production, IpS82, SpH84, and
SPH88 as well as RB80 standards have been bioas-
sayed monthly on their respective test insect (Figs.
1 and 2) and their LCro and LC- recorded. During
the test period, all flasks were stored at 4.C and i
new flask was opened for each bioassay. The 3 B.
sphaericus standards were always bioassayed on
the same day using the same larval mosquito pop-
ulation. At least 12 bioassays were performed each
year, and all measurement values were included in
order to observe the range of possible variations,
despite the strict titration and rearing methods used.
In all cases, rearing conditions were standardized
as much as possible. Standardization of rearing Cu-
lex larvae was much more difficult than that of Ae-
des larvae. Indeed,, Aedes eggs could be stored, des-
sicated, and hatched simultaneously. Aedes larvae
reached the early 4th instar within 4-5 days at 25"C
(when larval density was about 70O larvae per 2
liters with 3 cat food pellets (Friskies@, Friskies
PetCare Company Inc., Glendale, CA) weighing ca.
0.3 g each). In contrast, Cx. pipiens rafts did not
hatch simultaneously and larvae had to be separated
during the first instars. Moreover, Culex larvae
were more sensitive to the presence of food, which
was needed when they were bioassayed. All of the
results were influenced by the physiologic state of
the larvae as well as by the person doing the bio-
assay. From 1984 to 1992, one person performed
the bioassays and from 1993 to 1997, they were
performed by another person. However, the most
important source of variation in the bioassay was
the way that the larvae were fed during the larval
rearing (Skovmand et al. 1998).
In Figure 1, we show that the RB80 standard
fluctuates greatly within each year and through the
years; this fluctuation calls into question the utility
of RB80 as a standard: in contrast the SPH84 and
SPH88 standaf,ds showed less variation. Indeed, the
LCro mean -r SD over the 16-year evaluation of
RB80 was 0.018 -+ 0.0054 mg/liter (CY:29Vo vari-
ation), the SPH84 l4-year mean -f SD was 0.011
+ O.0Ol9 mg/liter (CY:. ITVo variation), and the
SPH88 9-year mean + SD was 0.0091 -r 0.0018
mg/liter (CY: l9Vo variation), where SD is the stan-
dard deviation and CV is the coefficient of varia-
tion. These numbers represent the average of the
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means over each year's time. Based upon these re-
sults we considered SPH84 and SPH88 to be good
standard powders. In the case of the IPS82 standard
(Fig. 2), the LCro mean + SD at 24 h of larval
exposure over the 16-year evaluation was 0.012 +
0.0020 mg/liter given a 16%o coefficient of varia-
tion. The lowest variation was observed after 48 h
of larval exposure with ttre LCro mean + SD :
0.0091 + 0.0012 mg/liter (CY: 13Vo variation).
These results indicate that IPS82 is still a good
standard powder. The variations in the larvicidal
activities were mostly due to the physiologic state
of the larvae and to the method of performing the
bioassay, rather than to the loss of activity of the
powders.
We tested the standard to determine whether,
when in stock-suspension, it could be kept for years
at 4oC. The SPH88 standard has been kept in stock
suspension, containing 5,000 mg/liter, at 4t since
January 10, 1989. This suspension was the source
for the serial dilutions and was sealed after each
bioassay. The toxicity of this suspension was reg-
ularly checked on Cx. pipiens larvae until 1997 ('Ia-
ble l). The lethal concentrations were compared
with that of a fresh stock suspension bioassayed on
the same day and with the mean of the LCros over
the respective year. For 3 yems no variation in the
larvicidal activity of this suspension was noticed.
After 4 years, a slight decrease in potency was no-
ticed but it was not significantly different from the
global mean, whereas after 8 years of storage, the
suspension had a 2-fold reduction in potency. In
1997, a cell and spore count was performed from
the January 10, 1989 stock suspension and a sus-
pension used in October 1997 diluted to 1 mg pow-
der/ml. The stock suspension contained 3.4 -F 0.1
x 108 cells/mg and 3 + 0.3 X 108 spores/mg,
whereas a fresh suspension contained 3.07 -+ 0.06
x 10E cells/mg and 3.06 + 0.8 X 108 spores/mg
powder. Therefore, no increase had occurred in the
number of spores and no contamination by other
bacteria had occurred in the stock suspension that
had been stored for years. This showed that SPH88
powder could be stored in aqueous suspension for
3 years without change in its potency. A similar
experiment was performed with SPH84 and RB80
after 12 years of storage at 4'C (Table 2): at the
end of the test period a 3- to 4-fold decrease in
larvicidal activity of the stock suspension was ob-
served. Nevertheless, these results indicated that
the larvicidal activity of the SPH88 standard was
not easily degraded after being in aqueous suspen-
sion for many years.
This survey showed that IPS82 and SPH88 stan-
dard powders could still be used as reference ma-
terial, especially to rate B.t.i. and B. sphaericus
powders, respectively. The efficacy of a standard
product was questionable when we observed a vari-
ation in the standard bioassay (usually between 4
and 25Vo) and in product bioassays (usually more
variation than the standard). This might enhance the
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variations of the potency of a product. One must be
aware of the limitations of a standardized assav due
to the difficulty of standardizing living o.gurrir-.
and to the way larvae react to the product. There_
fore, an assay with a final CV of 302, should be
considered a reasonable result, based on our expe_
nglcg on bioassays of B. thuringlensls products.
This is the case even when the assay is p6rformed
under high-quality, standardized conditions (e.g.,
rearing, mosquito populations, standardized meth_
ods), as defined in Skovmand et al. (199g) and bv
Thi6ry et al. (1997).
Standardization is used less and less frequently
for B. thuringlensis products on Lepidoptera larvae
because of the variety of toxins commercially avail-
able and the high number of various target insects.
To have accurate potency ofbacterial products, one
wonders whether one standard should be made for
each toxin corresponding to one test insect and ac-
cording to the formulation to be assessed. Indeed,
Skovmand et al. (1997) have recently shown that
the slopes of the bioassay curves of B.r.i. fluid
products were steeper than those of B.t.i. powder
products. This would suggest that IPS82 powder
should only be used to assay B.r.l. powder products
and not those in fluid forms. Presently, most of
B.t.i. and B. sphaericus commercialized products
are made with strain 1884 (Vectobac@ and Bacti-
mos@ Abbott, Chicago, IL; Culinexo, Culinex
Gmbh, Waldsee, Germany; Tecknar@, Thermo Tril-
ogy Corporation, Columbia, MD) or 2362 (Yecto-
lex@ and Spherimos@, Abbott). Other commercially
used strains, such as strain C3-41 (Wuhan, China)
and B.lOl (Sphericide@, Biotech International Ltd.,
New Delhi, India) of B. sphaericu.s or strain 197
(Wuhan Institute of Virology, Wuhan, China) and
strain 164 (Bacticideo, Biotech International Ltd.,
New Delhi, India) of B.r.i. also contain the same
toxins. But when new B. thuringiensis products that
harbor mosquito toxins different from those of
B.r.i., such as B. thuringiensis var. medellin or var.
jegathesan, will be commercialized, we will face a
problem similar to that of the B. thuringiensis stan-
dard for Lepidoptera products. In such a case, the
validity of the standardization assay, the aim of
which is to check the quantity of aciive ingredient
and- !!e homogeneity and stability of a iroduct,
could be called into question.
We thank V. Patricio for help in mosquito rearing
and bioassays performed since 1993.
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